Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy

Background: Cancer is a group of diseases involving an abnormal growth of cells which tend to proliferate in an uncontrolled fashion and in some cases metastasize to the surrounding tissues (malignancy). Resistance to chemotherapy is typically intrinsic (heterogeneity); however, acquired resistance...

Full description

Bibliographic Details
Published in:Trends in Food Science and Technology
Main Author: Khan S.; Imran M.; Butt T.T.; Ali Shah S.W.; Sohail M.; Malik A.; Das S.; Thu H.E.; Adam A.; Hussain Z.
Format: Review
Language:English
Published: Elsevier Ltd 2018
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050910410&doi=10.1016%2fj.tifs.2018.07.026&partnerID=40&md5=954103e0b3db253cf01cb8d5e7bdfa51
id 2-s2.0-85050910410
spelling 2-s2.0-85050910410
Khan S.; Imran M.; Butt T.T.; Ali Shah S.W.; Sohail M.; Malik A.; Das S.; Thu H.E.; Adam A.; Hussain Z.
Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
2018
Trends in Food Science and Technology
80

10.1016/j.tifs.2018.07.026
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050910410&doi=10.1016%2fj.tifs.2018.07.026&partnerID=40&md5=954103e0b3db253cf01cb8d5e7bdfa51
Background: Cancer is a group of diseases involving an abnormal growth of cells which tend to proliferate in an uncontrolled fashion and in some cases metastasize to the surrounding tissues (malignancy). Resistance to chemotherapy is typically intrinsic (heterogeneity); however, acquired resistance has also become prevelant due to multiple factors including expression of energy-dependent transporters causing expulsion of internalized drug contents extracellular, insensitivity of tumor cells to drug-induced apoptosis, and induction of drug-detoxifying mechanisms. Curcumin (CUR) has gained widespread recognition due to remarkable anticancer, anti-mutagenic, and anti-metastasizing potentials via downregulation of proliferation of cancer cells and induction of apoptosis. Nevertheless, pharmaceutical significance and therapeutic feasibility of CUR is restricted due to intrinsic physicochemical characteristics including poor aqueous solubility, inadequate biological stability, low bioavailability, and short half-life. Scope and approach: Owing to these pharmaceutical limitations of CUR, nanodelivery systems have attained remarkable fascination in the recent years. Therefore, this review was aimed to overview and critically ponders recent developments in improving anticancer viability of CUR. Key findings and conclusion: Critical analysis of the literature revealed that nanodelivery systems showed promising efficiency in achieving tumor specific targetability, maximizing internalization of drugs into cancer cells, mitigating tumor metastasis, as well as improving anticancer efficacy of CUR. Moreover, nanocarrier-mediated improved pharmacokinetics, drug accumulation, induced promising cytotoxicity, and enhanced anticancer efficacy by suppressing Egr-1 induction, Mitogen-activated protein kinase (MAPK) pathway, and protein tyrosine kinase (PTK) cascades while mitigating the progression of tumor, have also been discussed. © 2018 Elsevier Ltd
Elsevier Ltd
9242244
English
Review

author Khan S.; Imran M.; Butt T.T.; Ali Shah S.W.; Sohail M.; Malik A.; Das S.; Thu H.E.; Adam A.; Hussain Z.
spellingShingle Khan S.; Imran M.; Butt T.T.; Ali Shah S.W.; Sohail M.; Malik A.; Das S.; Thu H.E.; Adam A.; Hussain Z.
Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
author_facet Khan S.; Imran M.; Butt T.T.; Ali Shah S.W.; Sohail M.; Malik A.; Das S.; Thu H.E.; Adam A.; Hussain Z.
author_sort Khan S.; Imran M.; Butt T.T.; Ali Shah S.W.; Sohail M.; Malik A.; Das S.; Thu H.E.; Adam A.; Hussain Z.
title Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
title_short Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
title_full Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
title_fullStr Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
title_full_unstemmed Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
title_sort Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy
publishDate 2018
container_title Trends in Food Science and Technology
container_volume 80
container_issue
doi_str_mv 10.1016/j.tifs.2018.07.026
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050910410&doi=10.1016%2fj.tifs.2018.07.026&partnerID=40&md5=954103e0b3db253cf01cb8d5e7bdfa51
description Background: Cancer is a group of diseases involving an abnormal growth of cells which tend to proliferate in an uncontrolled fashion and in some cases metastasize to the surrounding tissues (malignancy). Resistance to chemotherapy is typically intrinsic (heterogeneity); however, acquired resistance has also become prevelant due to multiple factors including expression of energy-dependent transporters causing expulsion of internalized drug contents extracellular, insensitivity of tumor cells to drug-induced apoptosis, and induction of drug-detoxifying mechanisms. Curcumin (CUR) has gained widespread recognition due to remarkable anticancer, anti-mutagenic, and anti-metastasizing potentials via downregulation of proliferation of cancer cells and induction of apoptosis. Nevertheless, pharmaceutical significance and therapeutic feasibility of CUR is restricted due to intrinsic physicochemical characteristics including poor aqueous solubility, inadequate biological stability, low bioavailability, and short half-life. Scope and approach: Owing to these pharmaceutical limitations of CUR, nanodelivery systems have attained remarkable fascination in the recent years. Therefore, this review was aimed to overview and critically ponders recent developments in improving anticancer viability of CUR. Key findings and conclusion: Critical analysis of the literature revealed that nanodelivery systems showed promising efficiency in achieving tumor specific targetability, maximizing internalization of drugs into cancer cells, mitigating tumor metastasis, as well as improving anticancer efficacy of CUR. Moreover, nanocarrier-mediated improved pharmacokinetics, drug accumulation, induced promising cytotoxicity, and enhanced anticancer efficacy by suppressing Egr-1 induction, Mitogen-activated protein kinase (MAPK) pathway, and protein tyrosine kinase (PTK) cascades while mitigating the progression of tumor, have also been discussed. © 2018 Elsevier Ltd
publisher Elsevier Ltd
issn 9242244
language English
format Review
accesstype
record_format scopus
collection Scopus
_version_ 1809678483790495744